Co-Authors
This is a "connection" page, showing publications co-authored by DAVID GRAHAM and MASSIMO RUGGE.
Connection Strength
7.404
-
Gastric cancer risk in autoimmune gastritis: evidence versus opinion. Gut. 2024 02 23; 73(3):555-556.
Score: 0.958
-
Atrophic autoimmune gastritis: 'a muddled or misguided core concept compromises our overall comprehension of the problem'. Gut. 2023 12 07; 73(1):207-208.
Score: 0.944
-
Steps forward in understanding gastric cancer risk. Gut. 2023 09; 72(9):1802-1803.
Score: 0.867
-
Autoimmune gastritis: long-term natural history in na?ve Helicobacter pylori-negative patients. Gut. 2023 01; 72(1):30-38.
Score: 0.855
-
Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017 Dec; 15(12):1833-1843.
Score: 0.600
-
Clinical guidelines: Secondary prevention of gastric cancer. Nat Rev Gastroenterol Hepatol. 2012 Feb 14; 9(3):128-9.
Score: 0.416
-
Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol. 2011 Nov 07; 17(41):4596-601.
Score: 0.409
-
Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol. 2010 Mar; 44(3):167-72.
Score: 0.364
-
OLGA can guard the barn. Am J Gastroenterol. 2009 Dec; 104(12):3099; author reply 3101-2.
Score: 0.357
-
OLGA gastritis staging in young adults and country-specific gastric cancer risk. Int J Surg Pathol. 2008 Apr; 16(2):150-4.
Score: 0.318
-
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates. Gut. 2024 02 23; 73(3):407-441.
Score: 0.240
-
Diagnosis: gastric intestinal metaplasia - what to do next? Curr Opin Gastroenterol. 2019 11; 35(6):535-543.
Score: 0.178
-
Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging. Gut. 2020 06; 69(6):1151-1152.
Score: 0.173
-
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut. 2019 01; 68(1):11-17.
Score: 0.157
-
Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut. 2016 May; 65(5):721-5.
Score: 0.138
-
Autoimmune gastritis: Pathologist's viewpoint. World J Gastroenterol. 2015 Nov 14; 21(42):12179-89.
Score: 0.135
-
Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007 May; 56(5):631-6.
Score: 0.073
-
Clinical Manifestations of Helicobacter pylori-Negative Gastritis. Clin Gastroenterol Hepatol. 2017 Jul; 15(7):1037-1046.e3.
Score: 0.037
-
Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol. 2014 Mar; 109(3):357-68.
Score: 0.030
-
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol. 2013 Oct; 108(10):1576-83.
Score: 0.029
-
Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1374-84.
Score: 0.028
-
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):373-381.e1.
Score: 0.028
-
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013 Jan; 108(1):65-71.
Score: 0.027
-
Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis. 2011 Mar 01; 203(5):726-35.
Score: 0.024
-
Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas. Cancer Sci. 2009 May; 100(5):881-7.
Score: 0.021